Ulrich Derigs & Wolfgang Domschke 
Operations Research Proceedings 1997 [PDF ebook] 
Selected Papers of the Symposium on Operations Research (SOR’97) Jena, September 3-5, 1997

As with executives and managers in so many other business functions, pricing specialists are being challenged more and more to substantiate the added value of their activities. Pricing is a core func …

Environmental challenges have never been greater than today. There is the need for the utmost accuracy in the efforts to track the use, manufacture, processing, treatment, and disposal of toxic and h …

The book is divided into four parts: (1) foundations of qualitative research methods consisting of a chapter summarizing the various qualitative paradigms and a research methods chapter illuminating …

Do you struggle to get your ideas accepted and sometimes think, as people talk over you, perhaps I”m invisible? If so, this book will provide you with a road map for change. It presents the subject …

Leadership and organisational structures which are not adjusted to the cultural background of the employees concerned are most likely to produce sub-optimal results (House, 2004). Therefore it is nec …

In economic development, theory and practice exist as two seemingly separate realities. Academics strive to develop or refine theory by drawing on abstract concepts about the way people behave and in …

In 1987, Motorola developed Six Sigma out of a need for improvement in their pager manufacturing processes. Since then, Six Sigma has been implemented by a number of manufacturing companies, predomin …

The need for quality assurance in construction is now widely accepted. As a result, pressure is currently being applied to contractors and those offering professional services to demonstrate QA capab …

As organizations operate across countries and continents there is an increasing demand for the development of an HR function designed to deliver global support. This requires rethinking the structure …

In the US alone, pharmaceutical companies spend around $7 billion a year on clinical trials for drugs; all this in a global market where increasing competition and pressure on healthcare financing ar …